Stephanie Staelens

Stephanie joined Confo Therapeutics as Project Manager for Early Drug Discovery in July 2020 to coordinate new target identification, assessment and prosecution strategies as well as manage the early drug discovery activities.

Stephanie worked for over 10 years at Ablynx (Sanofi) where she headed the discovery phase of multiple therapeutic projects and amassed key expertise in VHH lead optimization. She also led multiple projects focused on platform improvement and extension. Before joining Confo Therapeutics Stéphanie worked for almost 2 years at Biotalys, where she played a key role in establishment of Biotalys’ VHH-based crop protection platform and led multiple discovery projects.

Stephanie has a PhD in biochemistry from KU Leuven (Belgium).